Analysis of L-myc and GSTM1 genotypes in Chinese non-small cell lung carcinoma

被引:37
作者
Ge, H
Lam, WK
Lee, J
Wong, MP
Yew, WW
Lung, ML
机构
[1] HONG KONG UNIV SCI & TECHNOL,DEPT BIOL,KOWLOON,HONG KONG
[2] UNIV HONG KONG,QUEEN MARY HOSP,DEPT MED,KOWLOON,HONG KONG
[3] GRANTHAM HOSP,TB & CHEST UNIT,KOWLOON,HONG KONG
[4] UNIV HONG KONG,QUEEN MARY HOSP,DEPT PATHOL,KOWLOON,HONG KONG
关键词
lung cancer; L-myc; GST; genotype;
D O I
10.1016/0169-5002(95)00598-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The genotypes of L-myc and GSTM1 genes were studied in normal lung tissues of 98 non-small cell lung carcinoma (NSCLC) patients from Hong Kong using polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP) techniques. Results showed a statistical difference in L-myc genotypes between Chinese and African Americans (P = 0.02). A significant deficit in heterozygotes resulting in the departure from Hardy-Weinberg equilibrium in lung cancer female patients was detected (0.01 < P < 0.02). There were significant differences in survival times in patients having L-L and S-S genotypes, with shorter survival times in the patients with L-L genotypes (0.01 < P < 0.05). Data on age, size of tumor, histological types, and lymph node metastasis showed no significant association with L-myc genotype. The survival time in the GSTM1-negative (null gene) group was significantly different from the GSTM1 positive group between 16 and 24 months after operation (0.01 < P < 0.05). There was no significant difference in the distribution of GSTM1 genotypes between Chinese and Caucasian Americans.
引用
收藏
页码:355 / 366
页数:12
相关论文
共 39 条
[1]  
AMBROSONE CB, 1995, CANCER RES, V55, P3483
[2]   METABOLIC OXIDATION PHENOTYPES AS MARKERS FOR SUSCEPTIBILITY TO LUNG-CANCER [J].
AYESH, R ;
IDLE, JR ;
RITCHIE, JC ;
CROTHERS, MJ ;
HETZEL, MR .
NATURE, 1984, 312 (5990) :169-170
[3]   Proportion of the GSTM1 0/0 genotype in some Slavic populations and its correlation with cystic fibrosis and some multifactorial diseases [J].
Baranov, VS ;
Ivaschenko, T ;
Bakay, B ;
Aseev, M ;
Belotserkovskaya, R ;
Baranova, H ;
Malet, P ;
Perriot, J ;
Mouraire, P ;
Baskakov, VN ;
Savitskyi, GA ;
Gorbushin, S ;
Deyneka, SI ;
Michnin, E ;
Barchuck, A ;
Vakharlovsky, V ;
Pavlov, G ;
Shilko, VI ;
Guembitzkaya, T ;
Kovaleva, L .
HUMAN GENETICS, 1996, 97 (04) :516-520
[4]   GENETIC-HETEROGENEITY OF THE HUMAN GLUTATHIONE TRANSFERASES - A COMPLEX OF GENE FAMILIES [J].
BOARD, P ;
COGGAN, M ;
JOHNSTON, P ;
ROSS, V ;
SUZUKI, T ;
WEBB, G .
PHARMACOLOGY & THERAPEUTICS, 1990, 48 (03) :357-369
[5]  
BROCKMOLLER J, 1993, CANCER RES, V53, P1004
[6]   LUNG-CANCER AND THE DEBRISOQUINE METABOLIC PHENOTYPE [J].
CAPORASO, NE ;
TUCKER, MA ;
HOOVER, RN ;
HAYES, RB ;
PICKLE, LW ;
ISSAQ, HJ ;
MUSCHIK, GM ;
GREENGALLO, L ;
BUIVYS, D ;
AISNER, S ;
RESAU, JH ;
TRUMP, BF ;
TOLLERUD, D ;
WESTON, A ;
HARRIS, CC .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (15) :1264-1272
[7]   ASSOCIATION BETWEEN RESTRICTION-FRAGMENT-LENGTH-POLYMORPHISM OF THE L-MYC GENE AND LUNG METASTASIS IN HUMAN BREAST-CANCER [J].
CHAMPEME, MH ;
BIECHE, I ;
LATIL, A ;
HACENE, K ;
LIDEREAU, R .
INTERNATIONAL JOURNAL OF CANCER, 1992, 50 (01) :6-9
[8]   RESTRICTION FRAGMENT LENGTH POLYMORPHISMS OF L-MYC AND MYB IN HUMAN-LEUKEMIA AND LYMPHOMA IN RELATION TO AGE-SELECTED CONTROLS [J].
CHENEVIXTRENCH, G ;
SOUTHALL, M ;
KIDSON, C .
BRITISH JOURNAL OF CANCER, 1989, 60 (06) :872-874
[9]  
Ge H, 1996, INT J CANCER, V69, P120, DOI 10.1002/(SICI)1097-0215(19960422)69:2<120::AID-IJC9>3.0.CO
[10]  
2-2